A GM-CSF and CD40L bystander vaccine is effective in a murine breast cancer model
Hatem Soliman,1 Melanie Mediavilla-Varela,2 Scott J Antonia,3 1Department of Women's Oncology and Experimental Therapeutics, 2Department of Immunology, 3Department of Thoracic Oncology, Moffitt Cancer Center, Tampa, FL, USA Background: There is increasing interest in using cancer vaccines t...
Guardado en:
Autores principales: | Soliman H, Mediavilla-Varela M, Antonia SJ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e50d07be5b5e4be5a7ca43898ee64387 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting Innate Immunity in Breast Cancer Therapy: A Narrative Review
por: Yanqi Ye, et al.
Publicado: (2021) -
Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment
por: Jagmohan Singh, et al.
Publicado: (2021) -
Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches
por: Ayoub NM, et al.
Publicado: (2019) -
TAPCells, the Chilean dendritic cell vaccine against melanoma and prostate cancer
por: Salazar-Onfray,Flavio, et al.
Publicado: (2013) -
Commensal <i>Bifidobacterium</i> Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines
por: Michele Tomasi, et al.
Publicado: (2021)